European Diabetes Working Party for Older People 2011 clinical guidelines for type 2 diabetes mellitus. Executive summary (Q37969988)

26 August 2017

European Diabetes Working Party for Older People 2011 clinical guidelines for type 2 diabetes mellitus. Executive summary (English)

1 reference

Isabelle Bourdel-Marchasson

26 August 2017

0 references

4

object named as

Isabelle Bourdel-Marchasson

1 reference

26 August 2017

Alan J Sinclair

1

1 reference

26 August 2017

Giuseppe Paolisso

2

1 reference

26 August 2017

Marta Castro

3

1 reference

26 August 2017

Roger Gadsby

5

1 reference

26 August 2017

Leocadio Rodriguez Mañas

6

1 reference

26 August 2017

European Diabetes Working Party for Older People

7

1 reference

26 August 2017

1 November 2011

1 reference

26 August 2017

Diabetes and Metabolism

1 reference

26 August 2017

37 Suppl 3

1 reference

26 August 2017

S27-38

1 reference

Survival as a function of HbA(1c) in people with type 2 diabetes: a retrospective cohort study

26 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2811%2970962-4

7 January 2021

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2811%2970962-4

7 January 2021

Combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes: New results from the ADVANCE trial

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2811%2970962-4

7 January 2021

Five-year incidence and progression of diabetic retinopathy in a defined older population: the Blue Mountains Eye Study

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2811%2970962-4

7 January 2021

Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2811%2970962-4

7 January 2021

Trends in the quality of care for elderly people with type 2 diabetes: the need for improvements in safety and quality (the 2001 and 2007 ENTRED Surveys).

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2811%2970962-4

7 January 2021

Standards of medical care in diabetes--2009.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2811%2970962-4

7 January 2021

SGS: a structured treatment and teaching programme for older patients with diabetes mellitus--a prospective randomised controlled multi-centre trial

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2811%2970962-4

7 January 2021

Healthy Changes for living with diabetes: an evidence-based community diabetes self-management program

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2811%2970962-4

7 January 2021

Nutrition education improves metabolic outcomes among older adults with diabetes mellitus: results from a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2811%2970962-4

7 January 2021

Follow-up report on the diagnosis of diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2811%2970962-4

7 January 2021

The underuse of screening services among elderly women with diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2811%2970962-4

7 January 2021

The value of glycosylated hemoglobin (HbA1c) as a predictive risk factor in the diagnosis of diabetes mellitus (DM) in the elderly.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2811%2970962-4

7 January 2021

Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2811%2970962-4

7 January 2021

Physical activity, body mass index, and diabetes risk in men: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2811%2970962-4

7 January 2021

Translating the diabetes prevention program into practice in the general community: findings from the Montana Cardiovascular Disease and Diabetes Prevention Program

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2811%2970962-4

7 January 2021

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2811%2970962-4

7 January 2021

10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2811%2970962-4

7 January 2021

Comorbidity and physical function: results from the aging and longevity study in the Sirente geographic area (ilSIRENTE study)

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2811%2970962-4

7 January 2021

Depression Predicts Increased Incidence of Adverse Health Outcomes in Older Mexican Americans With Type 2 Diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2811%2970962-4

7 January 2021

Determinants of functional outcome after revascularization for critical limb ischemia: an analysis of 1000 consecutive vascular interventions

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2811%2970962-4

7 January 2021

Disability and quality of life in elderly people with diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2811%2970962-4

7 January 2021

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2811%2970962-4

7 January 2021

Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists for preventing the progression of diabetic kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2811%2970962-4

7 January 2021

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2811%2970962-4

7 January 2021

Late referral--a major cause of poor outcome in the very elderly dialysis patient

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2811%2970962-4

7 January 2021

Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2811%2970962-4

7 January 2021

Aspirin is associated with reduced cardiovascular and all-cause mortality in type 2 diabetes in a primary prevention setting: the Fremantle Diabetes study

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2811%2970962-4

7 January 2021

Traditional risk factors for incident cardiovascular events have limited importance in later life compared with the health in men study cardiovascular risk score.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2811%2970962-4

7 January 2021

Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2811%2970962-4

7 January 2021

Meta-analysis of multiple primary prevention trials of cardiovascular events using aspirin

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2811%2970962-4

7 January 2021

Long-term effects of intensive glucose lowering on cardiovascular outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2811%2970962-4

7 January 2021

Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2811%2970962-4

7 January 2021

Management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2811%2970962-4

7 January 2021

Hypoglycaemia in elderly patients with diabetes mellitus: causes and strategies for prevention

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2811%2970962-4

7 January 2021

Survival in people with type 2 diabetes as a function of HbA(1c)

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2811%2970962-4

7 January 2021

Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2811%2970962-4

7 January 2021

JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2811%2970962-4

7 January 2021

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2811%2970962-4

7 January 2021

Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2811%2970962-4

7 January 2021

Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2811%2970962-4

7 January 2021

Prevalence of diabetes in care home residents

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2811%2970962-4

7 January 2021

Undiagnosed diabetes mellitus and metabolic control assessed by HbA(1c) among residents of nursing homes

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2811%2970962-4

7 January 2021

Diabetes care in extended-care facilities: appropriate intensity of care?

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2811%2970962-4

7 January 2021

Practical guidelines on the management and prevention of the diabetic foot: based upon the International Consensus on the Diabetic Foot (2007) Prepared by the International Working Group on the Diabetic Foot

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2811%2970962-4

7 January 2021

Diabetic foot disease in the elderly.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2811%2970962-4

7 January 2021

Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2811%2970962-4

7 January 2021

Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2811%2970962-4

7 January 2021

Postprandial plasma glucose excursions and cognitive functioning in aged type 2 diabetics.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2811%2970962-4

7 January 2021

Depression and poor glycemic control: a meta-analytic review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2811%2970962-4

7 January 2021

Diabetes mellitus, glycemic control, and incident depressive symptoms among 70- to 79-year-old persons: the health, aging, and body composition study.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2811%2970962-4

7 January 2021

Change in cognitive function by glucose tolerance status in older adults: a 4-year prospective study of the Rancho Bernardo study cohort

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2811%2970962-4

7 January 2021

Insulin resistance, diabetes and cognitive function: consequences for preventative strategies

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2811%2970962-4

7 January 2021

Risks of progression of retinopathy and vision loss related to tight blood pressure control in type 2 diabetes mellitus: UKPDS 69.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2811%2970962-4

7 January 2021

Sildenafil for treatment of erectile dysfunction in men with diabetes: a randomized controlled trial. Sildenafil Diabetes Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2811%2970962-4

7 January 2021

Vardenafil, a new phosphodiesterase type 5 inhibitor, in the treatment of erectile dysfunction in men with diabetes: a multicenter double-blind placebo-controlled fixed-dose study

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2811%2970962-4

7 January 2021

Phosphodiesterase inhibitors for erectile dysfunction in patients with diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2811%2970962-4

7 January 2021

Painful diabetic neuropathy is associated with greater autonomic dysfunction than painless diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2811%2970962-4

7 January 2021

The prevalence of peripheral neuropathy in a population-based study of patients with type 2 diabetes in Sweden

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2811%2970962-4

7 January 2021

Sensory and motor peripheral nerve function and lower-extremity quadriceps strength: the health, aging and body composition study

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2811%2970962-4

7 January 2021

A randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of ABT-594 in patients with diabetic peripheral neuropathic pain

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2811%2970962-4

7 January 2021

Risk factors for falls in older disabled women with diabetes: the women's health and aging study

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2811%2970962-4

7 January 2021

Multifactorial assessment and targeted intervention for preventing falls and injuries among older people in community and emergency care settings: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2811%2970962-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2811%2970962-4

7 January 2021

The relationship between glycemic control and falls in older adults

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2811%2970962-4

7 January 2021

Treadmill exercise and resistance training in patients with peripheral arterial disease with and without intermittent claudication: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2811%2970962-4

7 January 2021

Physical activity during daily life and mortality in patients with peripheral arterial disease

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2811%2970962-4

7 January 2021

Risk factors for declining ankle-brachial index in men and women 65 years or older: the Cardiovascular Health Study

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2811%2970962-4

7 January 2021

10.1016/S1262-3636(11)70962-4

Identifiers

DOI

1 reference

26 August 2017

1 reference